Auxellence Appoints Mr. York Lau as Board Advisor
Aug 19, 2016
OTC Disclosure News Service
Vancouver, BC, Canada
VANCOUVER, BC, Friday
August 19th, 2016 – Auxellence Health Corporation (CSE: AID, OTCQB:
AXHLF) (“Auxellence” or the “Company”) is pleased to announce the appointment
of Mr. York (Hong Ming) Lau as an advisor to the board for strategic planning
in the Asia Pacific region. Over the
past 28 years, Mr. York Lau has served in senior management and officer
positions as Vice President and President of finance companies in Asia as well as
Marketing Director of a China based asset management corporation.
“We are pleased
to welcome Mr. York Lau to our team, and expect he will be a valuable resource for
advice on overseas initiatives.” said Sydney Au, Chairman and CEO.
About Auxellence Health Corporation (CSE: AID,
Auxellence was founded in 2013 to
provide online services for resolving common health problems.
The company offers a physiologically
interactive computing platform that integrates medical devices and artificial
intelligence applications into a fully automated, personal health management
system for hypertension, arrhythmia, diabetes, and obesity.
The current focus is on the
normalization of cardiometabolic power in terms of blood pressure, blood
glucose, and body weight – and the monitoring of the physiological response to
medical solicitations, mainly medication, diet, exercise, and lifestyle
The TULIP™ system is an online
self-service intended for adults interested in normalizing blood pressure,
heart rate and rhythm, blood glucose, and body weight. Measurement procedures,
conditioning protocols, and session schedules are prescribed automatically from
data acquired by the user’s TULIP™ device – a blood pressure monitor with
interactive protocols that can feed medical records and expert systems useful
in testing, tracking and treating common health conditions.
The Tulip™ medical device
has received Health Canada and CE Mark certifications.
– Forward Looking Statements
news release may contain forward-looking statements based on assumptions and
judgments of management regarding future events or results. Such statements are
subject to a variety of risks and uncertainties which could cause actual events
or results to differ materially from those reflected in the forward looking
statements. The company disclaims any intention or obligation to revise or
update such statements. For a description of the risks and uncertainties facing
the Company and its business and affairs, readers should refer to the Company’s
Management’s Discussion and Analysis and other disclosure filings with Canadian
securities regulators which is posted on www.sedar.com,
and on http://thecse.com/en/listings/technology/auxellence-health-corporation.
news release does not constitute an offer to sell or solicitation of an offer
to buy any of the securities described herein and accordingly undue reliance
should not be put on such. Neither the Canadian Securities Exchange (CSE or
CNSX Markets), nor its Regulation Services Provider (as that term is defined in
policies of the CSE) accepts responsibility for the adequacy or accuracy of
This news release does not constitute an offer to
sell or a solicitation of an offer to buy any of the securities described
herein in the United States. The securities described herein have not been
registered under the United States Securities Act of 1933, as amended (the
“U.S. Securities Act”), or any state securities law and may not be offered or
sold in the “United States”, as such term is defined in Regulation S
promulgated under the U.S. Securities Act, unless registered under the U.S.
Securities Act and applicable state securities laws or an exemption from such
registration requirements is available.
This release includes additional documents. Select the link(s) below to view.
Auxellence – PR Aug 19 2016_York LAU appointed to Advisory Board.pdf
Copyright © 2016 OTC Markets. All Rights Reserved
The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.